Stock FAQs

what happened to nnox stock

by Winfield Cassin Published 3 years ago Updated 2 years ago
image

How much did nnox raise in its IPO?

Shares of Nano-X Imaging (NASDAQ: NNOX), commonly referred to as Nanox, fell 29.5% in December, according to data provided by S&P Global Market Intelligence. The company did get Food and Drug...

Where can I buy shares of nnox?

Revenue has started to flow into ambitious next-generation medical technology specialist Nano-X Imaging (NASDAQ: NNOX), also known as Nanox. Investors were handsomely rewarding the company for this...

Why did Nano-X imaging stock jump higher on Tuesday?

Aug 10, 2021 · What happened Shares of medical-imaging company Nano-X Imaging ( NNOX 4.30% ), commonly referred to as Nanox, plunged on Tuesday following the release of financial results for the second quarter of...

Why did Noxell Corporation change its name?

Apr 14, 2022 · Negative. Very Negative. Source. Headline. Nano-X Imaging (NASDAQ:NNOX) Trading Down 7.2%. americanbankingnews.com - April 8 at 1:54 PM. Nano-X Imaging (NASDAQ:NNOX) Shares Gap Up to $13.39. americanbankingnews.com - April 6 at 2:48 PM. Nano-X Imaging (NASDAQ:NNOX) Sees Strong Trading Volume.

image

Is NNOX stock a good buy?

Out of 3 analysts, 1 (33.33%) are recommending NNOX as a Strong Buy, 0 (0%) are recommending NNOX as a Buy, 2 (66.67%) are recommending NNOX as a Hold, 0 (0%) are recommending NNOX as a Sell, and 0 (0%) are recommending NNOX as a Strong Sell.

Did NNOX get FDA approval?

On Dec. 15, Nanox AI received FDA clearance for software that can detect lesions shown in medical images.Jan 5, 2022

Why is NNOX tanking?

Nano-X Imaging (NASDAQ:NNOX) has lost ~5.2% in the pre-market after revealing an investigation by the U.S. Securities & Exchange Commission (SEC) into the potential violation of federal securities laws by the company.Nov 17, 2021

How many shares of NNOX are there?

Share StatisticsAvg Vol (3 month) 3702.85kShares Outstanding 547.88MImplied Shares Outstanding 6N/AFloat 834.49M% Held by Insiders 117.88%7 more rows

What does NNOX company do?

Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.

Is Nano-X Imaging a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nano-X Imaging in the last twelve months. There are curr...

When is Nano-X Imaging's next earnings date?

Nano-X Imaging is scheduled to release its next quarterly earnings announcement on Thursday, March 31st 2022. View our earnings forecast for Nano-...

How can I listen to Nano-X Imaging's earnings call?

Nano-X Imaging will be holding an earnings conference call on Thursday, March 31st at 8:30 AM Eastern. Interested parties can register for or liste...

How were Nano-X Imaging's earnings last quarter?

Nano-X Imaging Ltd. (NASDAQ:NNOX) issued its quarterly earnings data on Tuesday, November, 16th. The company reported ($0.28) EPS for the quarter,...

What price target have analysts set for NNOX?

2 analysts have issued 12-month price targets for Nano-X Imaging's shares. Their forecasts range from $52.00 to $52.00. On average, they expect Nan...

Who are Nano-X Imaging's key executives?

Nano-X Imaging's management team includes the following people: Mr. Ran Poliakine , Founder, Chairman & CEO (Age 53) Mr. Itzhak Maayan , Chief...

Who are some of Nano-X Imaging's key competitors?

Some companies that are related to Nano-X Imaging include Koninklijke Philips (PHG) , Hologic (HOLX) , Butterfly Network (BFLY) , Hyperfine (HY...

What other stocks do shareholders of Nano-X Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nano-X Imaging investors own include NVIDIA (NVDA) , Adva...

When did Nano-X Imaging IPO?

(NNOX) raised $100 million in an initial public offering on Friday, August 21st 2020. The company issued 5,900,000 shares at $16.00-$18.00 per shar...

When is Nanox 2021?

Why are X-ray machines so large?

Company to host webcast on Monday, August 16th at 8:30 am ETNEVE ILAN, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that the Company will host a Business Update Video Presentation on Monday, ...

When did Nano X Imaging IPO?

The reason X-ray machines are so large is that they rely on the Rontgen thermionic effect , discovered in 1895 by German physicist Wilhelm Rontgen.

When will Nano X Imaging release its next earnings?

When did Nano-X Imaging IPO? (NNOX) raised $100 million in an initial public offering on Friday, August 21st 2020. The company issued 5,900,000 shares at $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets acted as the underwriters for the IPO and National Securities Corp. was co-manager.

Investors are nervous about the company's long-term ability to create shareholder value

Nano-X Imaging is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021. View our earnings forecast for Nano-X Imaging.

What happened

I've been a contributor with the Motley Fool since 2019 and it's been a supreme joy to try to help make the world a little smarter, happier, and richer every day. What's great about exploring business and the economy is the insight it gives you into how things are in the world.

So what

Shares of medical-imaging company Nano-X Imaging ( NASDAQ:NNOX), commonly referred to as Nanox, plunged on Tuesday following the release of financial results for the second quarter of 2021. The company's net loss widened significantly compared to the previous year, but it's doubtful that this is the reason the stock sold off.

Now what

Nanox is a pre-revenue company. In June, the company submitted its primary medical-imaging device -- the multi-source Nanox.ARC -- for approval from the U.S. Food and Drug Administration, but is still waiting on that. Because it's still pre-revenue, its net loss of $13.6 million (more than double last year's net loss) isn't all that surprising.

Recently Viewed Tickers

Right now, an investing thesis in Nanox stock remains unchanged: This company needs FDA approval of its multi-source Nanox.ARC so it can begin production and commercialization. Only then can it really build a global radiology platform that can reward shareholders. That's still going to take time and money.

Nano-X Imaging Ltd

Visit a quote page and your recently viewed tickers will be displayed here.

What happened

Nano-X Imaging Ltd. engages in the development of medical imaging systems.

So what

Shares of Nano-X Imaging (NASDAQ: NNOX), commonly referred to as Nanox, fell 29.5% in December, according to data provided by S&P Global Market Intelligence. The stock price just keeps tumbling for the company that aspires to revolutionize the X-ray industry, having now declined 84% from its high in 2021.

Now what

Nanox plans to commercialize a medical device called the multi-source Nanox.ARC, which can quickly and cheaply make a digital X-ray. It plans to make these devices available free to speed their adoption and charge a usage-based fee. It refers to this business model as medical screening as a service (MSaaS).

The Motley Fool

As of the third quarter, Nanox claimed to have MSaaS contracts for 6,500 multi-source Nanox.ARC systems. When the company went public, it said it was targeting 15,000 machines deployed by 2024. So it's making significant progress with the agreements it will need to pull this off.

What year did Procter and Gamble buy Noxell?

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community.

What was Noxzema's success story?

On September 22nd, 1989, The New York Times ran a story announcing that Procter & Gamble had agreed to acquire the Noxell Corporation for $1.3 billion. Noxell stockholders received a windfall that represented “nearly 25 times 1988 earnings” at a time when sales growth had begun to falter relative to its breakneck record due to the near ubiquity of the products it sold – you’d have been hard pressed to find a home in the country that didn’t have one of the famous blue jars stowed away in a bathroom or vanity. Specifically Procter & Gamble agreed to pay the owners of Noxell 0.272 shares of P&G for every Noxell or Noxell Class B share they held. The deal came after 1988 results revealed $521 million in sales; a year during which revenue increased 7% and net earnings 17%. Procter & Gamble funded the deal by issuing new shares of stock, diluting existing owners, banking on its ability to rationalize the two empires into a more efficient, streamlined, profitable undertaking. The entire thing was completed tax-free, allowing the Bunting heirs to enjoy a much more diversified portfolio of subsidiaries while collecting dividends from the Ohio-based consumer staples giant. Interestingly, the merger came out of the blue. Noxell wasn’t for sale at the time, it was Procter & Gamble’s executives who came knocking and offered a price so attractive the controlling family couldn’t say no.

How much did the Buntings donate to cancer research?

Noxzema was an American success story. A gifted doctor, with a scientific background, made a great product that worked. He sold it at a price anyone could afford. In the process, he made life better for countless people, enriched his employees, and built a jaw-dropping stream of income for his heirs.

Who invented noxzema?

Over time, as the brands were brought further into the orbit of Cincinnati, the Buntings turned their attention to philanthropy, donating tens of millions of dollars to worthy causes, including a $10 million gift to cancer research at Johns Hopkins.

Is Noxzema a girl's treatment?

Dr. George Bunting, Believed to Be the Inventor of Noxzema. Thrilled with his creation, Townsend wanted it to spread. By some accounts, he gave the formula to another physician, Dr. George Bunting of Baltimore, who decided to package and sell it in his own backyard. By other accounts, Bunting developed his own version and had no connection ...

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9